Tearscience, Inc.
Records under this name other than the patents Tearscience, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 46 patents it holds.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 10,940,074 | Melting meibomian gland obstructions Term ended Term ended Aug 9, 2026 · From the USPTO record | Term ended | Term ended Aug 9, 2026 | From the USPTO record |
| US 9,999,346 | Background reduction apparatuses and methods of ocular surface interferometry (OSI) employing polarization for imaging, processing, and/or displaying an ocular tear film Lapsed on the fee record Ended Jun 19, 2026 · From the USPTO record | Lapsed on the fee record | Ended Jun 19, 2026 | From the USPTO record |
| US 7,833,205 | Methods for Treating Meibomian Gland Dysfunction Employing Fluid Jet Term ended Term ended Jun 12, 2026 · High confidence | Term ended | Term ended Jun 12, 2026 | High confidence |
| US 9,993,151 | Full-eye illumination ocular surface imaging of an ocular tear film for determining tear film thickness and/or providing ocular topography Lapsed on the fee record Ended Jun 12, 2026 · From the USPTO record | Lapsed on the fee record | Ended Jun 12, 2026 | From the USPTO record |
| US 8,187,310 | Method and Apparatus for Treating Gland Dysfunction Term ended Ended no later than May 15, 2026 · Low confidence | Term ended | Ended no later than May 15, 2026 | Low confidence |
| US 8,187,311 | Method and Apparatus for Treating Gland Dysfunction Term ended Ended no later than May 15, 2026 · Low confidence | Term ended | Ended no later than May 15, 2026 | Low confidence |
| US 8,523,928 | System for Inner Eyelid Heat and Pressure Treatment for Treating Meibomian Gland Dysfunction Term ended Ended no later than May 15, 2026 · Low confidence | Term ended | Ended no later than May 15, 2026 | Low confidence |
| US 8,617,229 | System for Outer Eyelid Heat and Pressure Treatment for Treating Meibomian Gland Dysfunction Term ended Ended no later than May 15, 2026 · Low confidence | Term ended | Ended no later than May 15, 2026 | Low confidence |
| US 9,216,028 | Apparatuses for Treatment of Meibomian Glands Term ended Term ended May 15, 2026 · Medium confidence | Term ended | Term ended May 15, 2026 | Medium confidence |
| US 10,905,898 | Methods and apparatuses for treating gland dysfunction Term ended Ended no later than May 15, 2026 · From the USPTO record | Term ended | Ended no later than May 15, 2026 | From the USPTO record |